Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1997 Jun 1;324(Pt 2):619–626. doi: 10.1042/bj3240619

A soluble 3-hydroxy-3-methylglutaryl-CoA reductase in the protozoan Trypanosoma cruzi.

J Peña-Díaz 1, A Montalvetti 1, A Camacho 1, C Gallego 1, L M Ruiz-Perez 1, D Gonzalez-Pacanowska 1
PMCID: PMC1218474  PMID: 9182726

Abstract

We report the isolation and characterization of a genomic clone containing the open reading frame sequence for 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase from Trypanosoma cruzi, the causative agent of Chagas' disease. The protozoan gene encoded for a smaller polypeptide than the rest of the genes described from eukaryotic organisms and the deduced amino acid sequence could be aligned with the C-terminal half of animal and plant reductases exhibiting pronounced similarity to other eukaryotic counterparts. Further examination of the 5' flanking region by cDNA analysis and establishment of the splice acceptor sites clearly indicated that the corresponding mRNA apparently lacks sequences encoding a membrane N-terminal domain. The reductase gene is a single copy and is located on a chromosome of 1.36 Mb as determined by contour-clamped homogeneous electric field electrophoresis. The overall cellular distribution of enzymic activity was investigated after differential centrifugation of Trypanosoma cell extracts. Reductase activity was primarily associated with the cellular soluble fraction because 95% of the total cellular activity was recovered in the supernatant and was particularly sensitive to proteolytic inactivation. Furthermore the enzyme can be efficiently overexpressed in a highly active form by using the expression vector pET-11c. Thus Trypanosoma cruzi HMG-CoA reductase is unique in the sense that it totally lacks the membrane-spanning sequences present in all eukaryotic HMG-CoA reductases so far characterized.

Full Text

The Full Text of this article is available as a PDF (615.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berman J. D., Goad L. J., Beach D. H., Holz G. G., Jr Effects of ketoconazole on sterol biosynthesis by Leishmania mexicana mexicana amastigotes in murine macrophage tumor cells. Mol Biochem Parasitol. 1986 Jul;20(1):85–92. doi: 10.1016/0166-6851(86)90145-3. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1006/abio.1976.9999. [DOI] [PubMed] [Google Scholar]
  3. Cabrera J. A., Bolds J., Shields P. E., Havel C. M., Watson J. A. Isoprenoid synthesis in Halobacterium halobium. Modulation of 3-hydroxy-3-methylglutaryl coenzyme a concentration in response to mevalonate availability. J Biol Chem. 1986 Mar 15;261(8):3578–3583. [PubMed] [Google Scholar]
  4. Coderre J. A., Beverley S. M., Schimke R. T., Santi D. V. Overproduction of a bifunctional thymidylate synthetase-dihydrofolate reductase and DNA amplification in methotrexate-resistant Leishmania tropica. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2132–2136. doi: 10.1073/pnas.80.8.2132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Coppens I., Bastin P., Levade T., Courtoy P. J. Activity, pharmacological inhibition and biological regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in Trypanosoma brucei. Mol Biochem Parasitol. 1995 Jan;69(1):29–40. doi: 10.1016/0166-6851(94)00192-p. [DOI] [PubMed] [Google Scholar]
  6. Coppens I., Courtoy P. J. Exogenous and endogenous sources of sterols in the culture-adapted procyclic trypomastigotes of Trypanosoma brucei. Mol Biochem Parasitol. 1995 Jul;73(1-2):179–188. doi: 10.1016/0166-6851(95)00114-g. [DOI] [PubMed] [Google Scholar]
  7. Frimpong K., Darnay B. G., Rodwell V. W. Syrian hamster 3-hydroxy-3-methylglutaryl-coenzyme A reductase expressed in Escherichia coli: production of homogeneous protein. Protein Expr Purif. 1993 Aug;4(4):337–344. doi: 10.1006/prep.1993.1044. [DOI] [PubMed] [Google Scholar]
  8. Garvey E. P., Santi D. V. Stable amplified DNA in drug-resistant Leishmania exists as extrachromosomal circles. Science. 1986 Aug 1;233(4763):535–540. doi: 10.1126/science.3726545. [DOI] [PubMed] [Google Scholar]
  9. Gil G., Faust J. R., Chin D. J., Goldstein J. L., Brown M. S. Membrane-bound domain of HMG CoA reductase is required for sterol-enhanced degradation of the enzyme. Cell. 1985 May;41(1):249–258. doi: 10.1016/0092-8674(85)90078-9. [DOI] [PubMed] [Google Scholar]
  10. Goad L. J., Holz G. G., Jr, Beach D. H. Sterols of Leishmania species. Implications for biosynthesis. Mol Biochem Parasitol. 1984 Feb;10(2):161–170. doi: 10.1016/0166-6851(84)90004-5. [DOI] [PubMed] [Google Scholar]
  11. Gould S. J., Keller G. A., Hosken N., Wilkinson J., Subramani S. A conserved tripeptide sorts proteins to peroxisomes. J Cell Biol. 1989 May;108(5):1657–1664. doi: 10.1083/jcb.108.5.1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grellier P., Valentin A., Millerioux V., Schrevel J., Rigomier D. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors lovastatin and simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes. Antimicrob Agents Chemother. 1994 May;38(5):1144–1148. doi: 10.1128/aac.38.5.1144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Henriksson J., Aslund L., Pettersson U. Karyotype variability in Trypanosoma cruzi. Parasitol Today. 1996 Mar;12(3):108–114. doi: 10.1016/0169-4758(96)80670-3. [DOI] [PubMed] [Google Scholar]
  14. Jingami H., Brown M. S., Goldstein J. L., Anderson R. G., Luskey K. L. Partial deletion of membrane-bound domain of 3-hydroxy-3-methylglutaryl coenzyme A reductase eliminates sterol-enhanced degradation and prevents formation of crystalloid endoplasmic reticulum. J Cell Biol. 1987 Jun;104(6):1693–1704. doi: 10.1083/jcb.104.6.1693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jordan-Starck T. C., Rodwell V. W. Pseudomonas mevalonii 3-hydroxy-3-methylglutaryl-CoA reductase. Characterization and chemical modification. J Biol Chem. 1989 Oct 25;264(30):17913–17918. [PubMed] [Google Scholar]
  16. Lam W. L., Doolittle W. F. Mevinolin-resistant mutations identify a promoter and the gene for a eukaryote-like 3-hydroxy-3-methylglutaryl-coenzyme A reductase in the archaebacterium Haloferax volcanii. J Biol Chem. 1992 Mar 25;267(9):5829–5834. [PubMed] [Google Scholar]
  17. Ley V., Andrews N. W., Robbins E. S., Nussenzweig V. Amastigotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells. J Exp Med. 1988 Aug 1;168(2):649–659. doi: 10.1084/jem.168.2.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McCarthy-Burke C., Taylor Z. A., Buck G. A. Characterization of the spliced leader genes and transcripts in Trypanosoma cruzi. Gene. 1989 Oct 15;82(1):177–189. doi: 10.1016/0378-1119(89)90043-7. [DOI] [PubMed] [Google Scholar]
  19. Mosley S. T., Brown M. S., Anderson R. G., Goldstein J. L. Mutant clone of Chinese hamster ovary cells lacking 3-hydroxy-3 -methylglutaryl coenzyme A reductase. J Biol Chem. 1983 Nov 25;258(22):13875–13881. [PubMed] [Google Scholar]
  20. Olender E. H., Simon R. D. The intracellular targeting and membrane topology of 3-hydroxy-3-methylglutaryl-CoA reductase. J Biol Chem. 1992 Feb 25;267(6):4223–4235. [PubMed] [Google Scholar]
  21. Ryder N. S. Mechanism of action and biochemical selectivity of allylamine antimycotic agents. Ann N Y Acad Sci. 1988;544:208–220. doi: 10.1111/j.1749-6632.1988.tb40405.x. [DOI] [PubMed] [Google Scholar]
  22. Shapiro D. J., Nordstrom J. L., Mitschelen J. J., Rodwell V. W., Schimke R. T. Micro assay for 3-hydroxy-3-methylglutaryl-CoA reductase in rat liver and in L-cell fibroblasts. Biochim Biophys Acta. 1974 Dec 29;370(2):369–377. doi: 10.1016/0005-2744(74)90098-9. [DOI] [PubMed] [Google Scholar]
  23. Skalnik D. G., Narita H., Kent C., Simoni R. D. The membrane domain of 3-hydroxy-3-methylglutaryl-coenzyme A reductase confers endoplasmic reticulum localization and sterol-regulated degradation onto beta-galactosidase. J Biol Chem. 1988 May 15;263(14):6836–6841. [PubMed] [Google Scholar]
  24. Sommer J. M., Wang C. C. Targeting proteins to the glycosomes of African trypanosomes. Annu Rev Microbiol. 1994;48:105–138. doi: 10.1146/annurev.mi.48.100194.000541. [DOI] [PubMed] [Google Scholar]
  25. Troke P. F., Marriott M. S., Richardson K., Tarbit M. H. In vitro potency and in vivo activity of azoles. Ann N Y Acad Sci. 1988;544:284–293. doi: 10.1111/j.1749-6632.1988.tb40414.x. [DOI] [PubMed] [Google Scholar]
  26. Urbina J. A., Lazardi K., Aguirre T., Piras M. M., Piras R. Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother. 1991 Apr;35(4):730–735. doi: 10.1128/aac.35.4.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Urbina J. A., Lazardi K., Marchan E., Visbal G., Aguirre T., Piras M. M., Piras R., Maldonado R. A., Payares G., de Souza W. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob Agents Chemother. 1993 Mar;37(3):580–591. doi: 10.1128/aac.37.3.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Urbina J. A., Vivas J., Visbal G., Contreras L. M. Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by delta 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole. Mol Biochem Parasitol. 1995 Jul;73(1-2):199–210. doi: 10.1016/0166-6851(95)00117-j. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES